[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 49, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 39, "title": "CTO & Director", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 54, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Mr. Andrew  Knowles M.Sc.", "title": "VP of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caitlin  Webster CIPD, M.Sc.", "title": "Director of Talent Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.53, "open": 3.8, "dayLow": 3.42, "dayHigh": 4.01, "regularMarketPreviousClose": 4.53, "regularMarketOpen": 3.8, "regularMarketDayLow": 3.42, "regularMarketDayHigh": 4.01, "payoutRatio": 0.0, "beta": 0.702, "forwardPE": -5.9242425, "volume": 13446937, "regularMarketVolume": 13446937, "averageVolume": 5022012, "averageVolume10days": 4285020, "averageDailyVolume10Day": 4285020, "bid": 3.88, "ask": 3.95, "bidSize": 29, "askSize": 41, "marketCap": 1170400000, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 6.515, "allTimeHigh": 71.91, "allTimeLow": 1.891, "priceToSalesTrailing12Months": 35.600437, "fiftyDayAverage": 5.0992, "twoHundredDayAverage": 3.600475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 942715072, "profitMargins": 0.0, "floatShares": 202749166, "sharesOutstanding": 299335048, "sharesShort": 53201052, "sharesShortPriorMonth": 44375292, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.17799999, "heldPercentInsiders": 0.22941999, "heldPercentInstitutions": 0.38846, "shortRatio": 8.47, "shortPercentOfFloat": 0.231, "impliedSharesOutstanding": 299335048, "bookValue": 3.571, "priceToBook": 1.0949314, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -165664992, "trailingEps": -0.57, "forwardEps": -0.66, "enterpriseToRevenue": 28.675, "enterpriseToEbitda": -4.317, "52WeekChange": 0.4380952, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 3.91, "targetHighPrice": 17.0, "targetLowPrice": 4.0, "targetMeanPrice": 9.16667, "targetMedianPrice": 8.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 553078016, "totalCashPerShare": 1.851, "ebitda": -218379008, "totalDebt": 142080000, "quickRatio": 9.496, "currentRatio": 11.073, "totalRevenue": 32876000, "debtToEquity": 14.108, "revenuePerShare": 0.111, "returnOnAssets": -0.10955, "returnOnEquity": -0.15642999, "grossProfits": -135880000, "freeCashflow": -207588000, "operatingCashflow": -80840000, "revenueGrowth": 1.333, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -2.90242, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "AbCellera Biologics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 7.670072, "postMarketPrice": 4.2099, "postMarketChange": 0.29989982, "regularMarketChange": -0.62, "regularMarketDayRange": "3.42 - 4.01", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5022012, "fiftyTwoWeekLowChange": 2.019, "fiftyTwoWeekLowChangePercent": 1.0676891, "fiftyTwoWeekRange": "1.891 - 6.515", "fiftyTwoWeekHighChange": -2.6049998, "fiftyTwoWeekHighChangePercent": -0.3998465, "fiftyTwoWeekChangePercent": 43.80952, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "earningsCallTimestampStart": 1762466400, "earningsCallTimestampEnd": 1762466400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.57, "epsForward": -0.66, "epsCurrentYear": -0.66, "priceEpsCurrentYear": -5.9242425, "fiftyDayAverageChange": -1.1891997, "fiftyDayAverageChangePercent": -0.233213, "twoHundredDayAverageChange": 0.309525, "twoHundredDayAverageChangePercent": 0.085967824, "corporateActions": [], "postMarketTime": 1762563559, "regularMarketTime": 1762549200, "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -13.6865, "regularMarketPrice": 3.91, "longName": "AbCellera Biologics Inc.", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]